E-LIB Suche - Ergebnisse für: van Hoogdalem, Ewoud-Jan

1

Disproportional inflation of clinical trial costs: why we s..:

Hijma, Hemme J. ; Zhuparris, Ahnjili ; van Hoogdalem, Ewoud-Jan.
Nature Reviews Drug Discovery. 23 (2024) 2 - p. 85-86 , 2024

Link: https://doi.org/10.1038/..

2

Pharmacokinetics, safety, and tolerability of fosmanogepix ..:

Hodges, Michael R. ; Hazel, Susan ; Kramer, William G....
Antimicrobial Agents and Chemotherapy. 68 (2024) 5 - p. , 2024

Link: https://doi.org/10.1128/..

3

Rethinking, reducing, and refining the classical oral tyram..:

van Hoogdalem, Ewoud‐Jan ; Smith, Karen L. ; Hartstra, Jan.
Clinical and Translational Science. 16 (2023) 10 - p. 2058-2069 , 2023

Link: https://doi.org/10.1111/..

4

Safety and Pharmacokinetics of Intravenous and Oral Fosmano..:

Hodges, Michael R. ; Ople, Eric ; Wedel, Pamela...
Antimicrobial Agents and Chemotherapy. 67 (2023) 4 - p. , 2023

Link: https://doi.org/10.1128/..

5

First-in-Human Study of the Safety, Tolerability, Pharmacok..:

van Hoogdalem, Ewoud-Jan ; Peeters-Scholte, Cacha M.P.C.D. ; Leufkens, Paul W.T.J....
Current Clinical Pharmacology. 15 (2020) 2 - p. 152-163 , 2020

Link: https://doi.org/10.2174/..

6

Metacommunication in social pretend play: two dimensions:

de Haan, Dorian ; Vriens-van Hoogdalem, Anne-Greth ; Zeijlmans, Kirti.
International Journal of Early Years Education. 29 (2020) 4 - p. 405-419 , 2020

Link: https://doi.org/10.1080/..

7

Ototopical drops containing a novel antibacterial synthetic..:

Peek, Nanno F. A. W. ; Nell, Marja J. ; Brand, Ronald...
PLOS ONE. 15 (2020) 4 - p. e0231573 , 2020

Link: https://doi.org/10.1371/..

8

Ototopical drops containing a novel antibacterial synthetic..:

Nanno F A W Peek ; Marja J Nell ; Ronald Brand...
https://doi.org/10.1371/journal.pone.0231573. , 2020

Link: https://doi.org/10.1371/..

9

First-in-Human Study to Assess Safety, Tolerability and Pha..:

Hodges, Michael R ; Ople, Eric ; Shaw, Karen J...
Open Forum Infectious Diseases. 4 (2017) suppl_1 - p. S526-S526 , 2017

Link: https://doi.org/10.1093/..

10

Phase 1 Study to Assess Safety, Tolerability and Pharmacoki..:

Hodges, Michael R ; Ople, Eric ; Shaw, Karen J...
Open Forum Infectious Diseases. 4 (2017) suppl_1 - p. S534-S534 , 2017

Link: https://doi.org/10.1093/..

11

The role of language ability in young children's cooperatio..:

Vriens-van Hoogdalem, Anne-Greth ; de Haan, Dorian M. P. ; Boom, Jan
Early Child Development and Care. 186 (2015) 9 - p. 1491-1504 , 2015

Link: https://doi.org/10.1080/..

12

Rate-controlled Absorption Enhancement of Rectally Administ..:

van Hoogdalem, Ewoud J ; Stijnen, Anna M ; de Boer, Albertus G.
Journal of Pharmacy and Pharmacology. 40 (2011) 5 - p. 329-332 , 2011

Link: https://doi.org/10.1111/..

13

In-vitro Metabolism of YM17E, an Inhibitor of Acyl Coenzyme..:

Uchida, Taisuke ; Watanabe, Takashi ; Van Hoogdalem, Ewoud J.
Journal of Pharmacy and Pharmacology. 48 (2011) 10 - p. 1049-1056 , 2011

Link: https://doi.org/10.1111/..

14

The influence of components on the rectal absorption of cef..:

van Hoogdalem, Ewoud J ; Geerts, Joan A M ; de Boer, Albertus G.
Journal of Pharmacy and Pharmacology. 40 (2011) 11 - p. 815-817 , 2011

Link: https://doi.org/10.1111/..

15

Evaluation of metabolite profiles as biomarkers for the pha..:

Van Doorn, Martijn ; Vogels, Jack ; Tas, Albert...
British Journal of Clinical Pharmacology. 63 (2007) 5 - p. 562-574 , 2007

Link: https://doi.org/10.1111/..